10,364
Total Publications
1,016,432
Total Citations
Top Researchers
- Tetsuo Noda 33,270 citations • 343 papers
- Takashi Tsuruo 32,693 citations • 604 papers
- Sadao Kimura 31,553 citations • 473 papers
- Makoto Nishio 31,006 citations • 852 papers
- Seigo Kitano 24,457 citations • 899 papers
- Shinji Ohno 23,354 citations • 564 papers
- Kensei Yamaguchi 21,901 citations • 914 papers
- Hiroshi Yoshida 21,732 citations • 1547 papers
- Kengo Takeuchi 21,316 citations • 722 papers
- Takeshi Sano 20,014 citations • 413 papers
Most Cited Papers
- Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer 2007 • 5,391 citations
- Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer 2011 • 2,811 citations
- First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial 2021 • 2,797 citations
- Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer 2017 • 2,484 citations
- Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1 1998 • 2,368 citations
- Induction of Apoptosis by ASK1, a Mammalian MAPKKK That Activates SAPK/JNK and p38 Signaling Pathways 1997 • 2,318 citations
- A cross-population atlas of genetic associations for 220 human phenotypes 2021 • 2,311 citations
- Visualizing Spatiotemporal Dynamics of Multicellular Cell-Cycle Progression 2008 • 2,281 citations
- Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial 2017 • 2,256 citations
- Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome 2013 • 2,157 citations